CLINICAL_TRIALS
trial_result
· 2012-06-13
Clinical Trial Update: Study of ONO-1101 in Patients Scheduled for Coronary Angiography [Phase 2]
Summary
Phase 2 study of ONO-1101 in patients scheduled for coronary angiography has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED